Qatar Biomedical Research Institute (QBRI), part of Hamad Bin Khalifa
University (HBKU), has won the prestigious Arab Best Research
Institution of the Year 2017 award, confirming the institute’s position
as a pioneer in the provision of healthcare solutions in Qatar, the
region, and the world. The award was presented at a ceremony recently in
Marrakech, Morocco.
The annual Arab Best Awards are among the most coveted in the region,
and aim to recognise exceptional organisations and professionals in the
Arab world. They aim to celebrate achievements in three core areas:
business excellence; government, leadership and sports; and social and
community contribution.
For QBRI, the award was a direct result of the institute’s ongoing
research efforts to provide new insights into the molecular basis of the
grand challenges of breast cancer, diabetes and neurological disorders
such as autism and neurodegenerative diseases.
“I am delighted that QBRI has been declared the Arab Best Research
Institution of the Year for 2017. Receiving this award is proof of our
enduring efforts to contribute to biomedical research in Qatar and the
world. It is another example of the hard work and dedication of QBRI’s
employees and researchers, and solidifies HBKU’s position as a
research-intensive university. This recognition inspires us to achieve
greater milestones, as we continue to pursue solutions for global health
challenges,” said Dr Omar El-Agnaf, acting executive director, QBRI.
The Arab Best Awards’ General Secretariat and Experts Committee also
selected Dr El-Agnaf as one of the Best 100 Arab CEOs, in recognition of
his contributions to research on Parkinson’s disease and related
disorders, as well as his vision as QBRI’s top manager.
Award categories are highly competitive and the winners are selected
based on a merit system that includes 17 criteria such as leadership
style; alignment to strategic business goals; administrative
productivity, among others.
Dr Omar El-Agnaf receiving the award.